SWOT Analysis for Allogene Therapeutics Inc

Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Annual Net Profits improving for last 2 years
Increasing profits every quarter for the past 2 quarters
Stock with Low PE (PE < = 10)

Negative Breakdown Second Support (LTP < S2)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
MACD crossed below zero line previous end of day
Top Losers
Negative Breakdown First Support (LTP < S1)
Negative Breakdown Second Support (LTP < S2)
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter